FACTORS INFLUENCING PROGNOSIS IN MYELOMATOSIS

被引：44

作者：

DAWSON, AA

OGSTON, D

机构：

来源：

POSTGRADUATE MEDICAL JOURNAL | 1971年 / 47卷 / 552期

关键词：

D O I：

10.1136/pgmj.47.552.635

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：635 / &

共 13 条

[1] TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS [J].

ALEXANIAN, R ;

HAUT, A ;

KHAN, AU ;

LANE, M ;

MCKELVEY, EM ;

MIGLIORE, PJ ;

STUCKEY, WJ ;

WILSON, HE .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) :1680-+

[2]

Bergsagel D E, 1967, Adv Cancer Res, V10, P311, DOI 10.1016/S0065-230X(08)60081-0

[3] MANAGEMENT OF MYELOMATOSIS [J].

BROAD, AF ;

EMERY, EW ;

GODLEE, JN ;

PRANKERD, TA .

POSTGRADUATE MEDICAL JOURNAL, 1968, 44 (516) :803-&

[4]

FEINLEIB M, 1960, J NATL CANCER I, V24, P1259

[5]

GALTON DAG, 1968, BRIT J HAEMATOL, V15, P319

[6]

Hellwig CA, 1943, ARCH PATHOL, V36, P95

[7] GROWTH RATES AND RESPONSES TO TREATMENT IN HUMAN MYELOMATOSIS [J].

HOBBS, JR .

BRITISH JOURNAL OF HAEMATOLOGY, 1969, 16 (06) :607-&

[8]

INNES J, 1961, LANCET, V1, P239

[9]

MARTIN NH, 1961, LANCET, V2, P237

[10] CYCLOPHOSPHAMIDE VS MELPHALAN IN TREATMENT OF PLASMA CELL MYELOMA [J].

RIVER, SL ;

PATNO, ME .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (07) :1328-&

← 1 2 →